Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01949376 · ClinicalTrials.gov registry record
Mild Cognitive Impairment in Breast Cancer Patients
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 84
- Enrollment target
NCT01949376 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 84 participants.
The verdict
NCT01949376 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to improve our understanding of potential changes in size, shape and activity in some brain areas that can occur in women receiving different types of Breast Cancer therapy, and how these changes are related to the development of mild cognitive impairment as the result of these treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2013-06 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01949376
The ClinicalTrials.gov registry entry for NCT01949376 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01949376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01949376 about?
NCT01949376 is a clinical study titled "Mild Cognitive Impairment in Breast Cancer Patients". The purpose of this study is to improve our understanding of potential changes in size, shape and activity in some brain areas that can occur in women receiving different types of Breast Cancer therapy, and how these changes are related to the development of mild cognitive impairment as the result o...
What is the current status of trial NCT01949376?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2013-06. Estimated completion is 2019-12-31.
Who is sponsoring clinical trial NCT01949376?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.